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Abstract.  We have studied the cytoskeletal association 
of intercellular  adhesion molecule-1  (ICAM-1, CD54), 
an integral  membrane protein that functions as a coun- 
terreceptor for leukocyte integrins  (CDll/CDI8).  A 
linkage between ICAM-1  and cytoskeletal elements 
was suggested by studies showing a different ICAM-1 
staining  pattern for COS cells transfected with wild- 
type ICAM-1 or with an ICAM-1 construct that replaces 
the cytoplasmic and transmembrane domains of ICAM-1 
with a glycophosphatidylinositol (GPI) anchor.  Wild- 
type ICAM-1  appeared to localize most prominently 
in microvilli whereas GPI-ICAM-1  demonstrated a 
uniform cell surface distribution.  Disruption of micro- 
filaments with cytochalasin B (CCB) changed the lo- 
calization of wild-type ICAM-1 but had no effect on 
GPI-ICAM-1.  Some B-cell lines demonstrated a prom- 
inent accumulation of ICAM-1  into the uropod region 
whereas other cell surface proteins examined were not 
preferentially localized.  CCB also induced redistribu- 
tion of ICAM-1  in these cells. For characterization  of 
cytoskeletal proteins interacting  with ICAM-1, a 28- 
residue peptide that encompasses the entire predicted 
cytoplasmic domain (ICAM-1,478_505) was synthesized, 
coupled to Sepharose-4B, and used as an affinity ma- 
trix.  One of the most predominant proteins eluted ei- 
ther with soluble ICAM-1,47s_505-peptide or EDTA, was 
100 kD, had a pI of 5.5,  and in Western blots reacted 
with ot-actinin  antibodies.  A direct association between 
ot-actinin  and ICAM-1  was demonstrated by binding of 
purified ot-actinin  to ICAM-1,47s_~05-peptide and to im- 
munoaffinity purified ICAM-1  and by a  strict colocal- 
ization of ICAM-1  with ot-actinin,  but not with the 
cytoskeletal proteins talin,  tensin,  and vinculin.  The 
region of ICAM-1,478_505 interacting  with o~-actinin was 
mapped to the area close to the membrane spanning 
region.  This region contains  several positively charged 
residues and appears to mediate a charged interaction 
with o~-actinin which is not highly dependent on the 
order of the residues. 
INKAGES between transmembrane proteins and cytoskel- 
etal  elements  are  crucial  for  a  variety  of cellular 
functions.  Such functions  include cell-ceU and cell- 
matrix interactions,  cell motility, maintenance  of cell polar- 
ity, and directed exocytosis and endocytosis. Most of the in- 
formation  regarding  the  transmembrane  and  cytoskeletal 
molecules that interact and support these functions originate 
from observations of their spatial arrangements  by immuno- 
staining methods. These studies have suggested, for instance, 
that membrane-cytoskeleton interactions  take place in spe- 
cialized contacts such as focal adhesions (12) or desmosomes 
(54) and during  internalization  of receptors through  coated 
pits (23). 
In  spite  of the valuable information  that  morphological 
analysis has provided, alternative  methods are required to 
study associations between transmembrane and cytoskeletal 
proteins at a molecular level.  Increasing  information  using 
various  techniques  has  accumulated  recently  about  such 
linkages but few studies have described specific interactions 
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between characterized proteins.  Using equilibrium chroma- 
tography, a cytoskeletal protein talin, was shown to interact 
with fibronectin  receptor (26),  with the aid of a synthetic 
peptide, the/~t subunit of the fibronectin receptor was shown 
to  associate  with  another  cytoskeletal protein,  ~actinin 
(40).  Using fusion proteins as an affinity matrix, an interac- 
tion between low density lipoprotein (LDL) ~  and mannose- 
6-phosphate  receptors  and  clathrin  adaptor  proteins  was 
characterized (21, 42). 
In this work we have studied that cytoskeletal associations 
of intercellular  adhesion  molecule-1  (ICAM-1, CD54),  an 
adhesion molecule that serves as a ligand for the leukocyte- 
integrins  LFA-1 and Mac-1 and as a receptor for the major 
group of human rhinoviruses  and strains of Plasmodiumfal- 
ciparum (5, 16, 24, 33, 46, 53). We show that ICAM-1 is as- 
sociated with the actin-containing  cytoskeleton and that this 
interaction  leads to a  specialized  cell surface distribution 
of ICAM-1 both on adherent COS cells and on Epstein-Barr 
virus (EBV)-transformed  B-cells. We further show evidence 
1. Abbreviations  used in this paper: CCB,  cytochalasin B; EBV, Epstein- 
Barr virus; GPI, glycophosphatidylinositol;  TSA, Tris-Saline-Azide. 
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with a stretch of charged residues in the ICAM-1 cytoplasmic 
domain  synthetic  peptide  and  in  cells  codistributes  with 
ICAM-1  suggesting  that it may  serve as an anchorage be- 
tween ICAM-1  and actin-containing cytoskeleton. 
Materials and Methods 
Cell Lines, cDNAs, and Antibodies 
JY, an EBV-transfected B-cell line, obtained from Dr. J. Strominger (Dana 
Farber Cancer  Institute,  Boston,  MA),  KOS  (29)  and  SLA  (2),  EBV- 
transfected B-cell lines established from patients with leukocyte adhesion 
deficiency (LAD) (1), Raji, a Burkitt's lymphoma line (43) and COS-7,  a 
monkey kidney epithelial cell line (22) were used in the studies. 
COS cells were transfected with ICAM-1 eDNA subcloned into CDM8 
expression vector (47) or with a construct, which replaces the transmem- 
brane and cytoplasmic domains with a glycophosphatidylinositol (GPI) an- 
chor. The construct was generated by replacing ICAM-1 eDNA encoding 
transmembrane and cytoplasmic domains with GPI signal sequence from 
LFA-3 (47). CDM8 vector alone was used as a control for transfections. 
Transfections were performed with the DEAE-dextran method as described 
(27). The cells were replated after 48 h and fixed for analysis 24-36 h later. 
A mixture of two mouse mAb, RR1/1 (46) and R6.5 (49) or CL203 (31), 
was used to detect ICAM-1. LFA-1 was stained with a combination of three 
mAb N217, N225, and N226 obtained from IVth Leukocyte Typing Work- 
shop (28). CD43 was detected with mAb N23, CD44 with mAb N85, and 
CD45 with mAb N88 all obtained from IVth Leukocyte Typing Workshop 
(Vienna). LFA-3 was detected with TS2/9 mAb (30), and class I MHC with 
mAb W6/32 (3). X63 IgG was used as a control mAb. Cytoskeletal proteins 
were detected with rabbit antisera against t~-actinin and talin (kindly pro- 
vided by K. Burridge, University of North Carolina, Chapel Hill, NC) (11, 
40), tensin (62) (kindly provided by L. B. Chen, Dana Farber Cancer Insti- 
tute, Boston, MA), and vinculin (kindly provided by I. Virtanen, University 
of Helsinki, Helsinki, Finland) (13). 
Indirect Immunofluorescence Microscopy 
Before fixation lymphoid cells were spun onto cytocentrifuge slides.  The 
slides and transfected COS cells grown on Permanex slides (Nunc, Ros- 
kilde, Denmark) were fixed in 3.5% paraformaldehyde in PBS, pH 7.4, at 
4~  for 10 min. For double staining of ICAM-1 and a-actinin the cells were 
fixed in  -20~  methanol,  mAb were used as  10 #g/mi of purified IgG 
(R6.5) diluted in PBS, as undiluted hybridoma culture supernatants (RR1/1, 
TS2/9, W6/32, X63) or as 1:500 dilution of ascites (workshop antibodies). 
The  slides  were  rinsed  and  reacted  with  FITC-conjugated  goat  F(ab')2 
anti-mouse Ig (Tago Inc., Buriingame, CA). For double stainings the cells 
were further permeahilized in 0.1% Triton X-100/PBS, stained with rabbit 
antisera  or  normal  rabbit  serum  (1:100  dilution)  and  with  rhodamine- 
conjugated  goat  F(ah')2  anti-rabbit Ig  (Tago  Inc.).  Double  staining  of 
ICAM-1  and c~-actinin  in methanol fixed slides was done according to a 
similar protocol except that 0.1% Triton X-100 was omitted. F-actin was de- 
tected with rhodamine-phallacidin (Molecular Probes Inc., Eugene, OR). 
The  slides  were  mounted  in  glycerol/PBS  and  viewed  with  a  Zeiss 
epifluorescence microscope (Carl Zeiss, Inc., Thornwood, NY) and pho- 
tographed with Kodak T-Max P3200 black and white film (Eastman Kodak 
Co.,  Rochester, NY). 
Modification of Cell Surface Distribution of  lCAM-1 
The following agents were tested for alteration of ICAM-I  distribution: 
NaN3 (Sigma Chemical Co., St. Louis, MO), final concentration 10 -3 M, 
colchicine (Sigma Chemical Co.) 10 #g/ml, cytochalasin B (CCB) (Calbio- 
chem Corp., La Jolla, CA) 10 #g/ml, EDTA (Sigma Chemical Co.) 10 mM 
and PMA (Calbiochem Corp.) 50 ng/ml. JY cells were treated with PMA 
for 20 rain and with other agents for 60-120 rain before preparation of the 
slides and fixation. After staining the distribution of ICAM-1 was analyzed 
from coded slides and at least 200 cells/slide were counted. 
Coupling of  Synthetic Peptides 
A  synthetic peptide corresponding to the 28-amino acid cytoplasmic do- 
main of ICAM-1  (ICAM-1,47s-5os)  (48,  51),  two shorter peptides  of the 
NH2-terminal region of ICAM-1 cytoplasmic domain, a peptide of ICAM-1 
cytoplasmic  amino  acids  in reverse order  (ICAM-1,505-47s) and  control 
peptide 4  were  synthesized with the  solid phase method  (34).  Peptides 
ICAM-1,47s_5os and ICAM-1,5os~tTS were synthesized with an Applied Bit- 
systems synthesizer (model 430; Applied Biosystems Inc., Foster City, CA) 
using small scale rapid cycle-tBOC chemistry option and were cleaved from 
the resin by HF. Peptides ICAM-1,47s-486 and ICAM-1,4so-4s4 were synthe- 
sized with an Applied Biosystems synthesizer (model 431) using the FMOC 
chemistry option and were cleaved by trifluoroacetic acid. All peptides were 
purified by reversed phase HPLC on a C18 column using aqueous trifluoro- 
acetic acid (0.1%)/acetonitrile-based mobile phases. Purified peptides were 
characterized by HPLC  and fast atom bombardment mass spectrometry. 
Three lysine-rich control peptides (nos.  1-3) were a kind gift from Dr. H. 
Rauvala (Department of Biochemistry, University of Helsinki). All peptides 
were coupled to CnBr-activated Sepharose 4B (Pharmacia Fine Chemicals, 
Piscataway,  NJ) at a concentration of 2  mg/mi except for ICAM-I,47s-505 
when used for affinity chromatography, in which case it was coupled at 4 
mg/ml. The efficiency of coupling was verified spectrophotometrically by 
absorption at 214 mn before and after coupling. Coupling efficiency always 
exceeded 95 %. After coupling, Sepharose was blocked with 1 M ethanol- 
amine, pH 9.0. 
Peptide  Affinity Chromatography 
Placental tissue was homogenized with a tissue grinder and solubilized in 
lysis buffer (50 mM octyl-fl-D-glucopyranoside, 50 mM Tris/HCl, pH 8.0, 
0.15  M  NaCI,  1  mM  MgCI2,  1 mM  CaC12,  0.5  mM  PMSE  5  #g/mi 
leupeptin).  Insoluble material was removed by centrifuging the lysate at 
100,000 g for 60 rain at 4~  and the lysate supernatant was filtered through 
a  Whatman  1 filter paper (Whatman Chemical Separation Inc.,  Clifton, 
N J). The lysate was passed through an ethanolamine-Sepharose precolunm 
and ICAM-1,47s_505-peptide-Sepharose  column.  The column was washed 
with 50 column volumes of lysis buffer. Bound material was eluted with 2 
mg/ml of soluble peptide in lysis buffer or with lysis buffer in which divalent 
cations were replaced with 10 mM EDTA, pH 8.0.  1.5-ml fractions were 
collected and analyzed by SDS-PAGE and silver staining (37). 
Western Blotting and Two-dimensional 
Gel Electrophoresis 
Material that eluted  from the ICAM-1,478_505-peptide-Sepharose  colunm 
was separated in 8%  SDS-PAGE minigels (Bio-Rad Laboratories,  Rich- 
mond, CA) and transferred to nitrocellulose paper (200 mA, 45 rain). The 
sheets were blocked in 2% BSA in Tris-Saline-Azide (TSA) (50 mM Tris/ 
HCI, pH 8.0, 0.15 M NaC1, 0.1% NAN3). The blots were reacted with rab- 
bit antisera against cytoskeletal proteins or with normal rabbit serum as a 
1:500 dilution in blocking buffer. The blots were washed twice with washing 
buffer (BSA/TSA/0.1%  NP-40),  incubated in  le5I-protein A  (Amersham 
Corp., Arlington Heights, IL) in BSA/TSA, washed twice, and autoradio- 
graphed. 
For two-dimensional (2-D) IEF SDS-PAGE eluted material was concen- 
trated with Centricon-30 microconcentrators (Amicon). The 2-D gel analy- 
sis was done using Mini-Protean II 2-D gel system (Bio-Rad Laboratories). 
Isoelectric focusing was performed according to the method by O'Farrell 
(39). Separated proteins were visualized by staining with Coomassie blue 
R-250. 
Iodination of Cytoskeletal Proteins 
Chicken gizzard c~-actinin purified as described (20) was kindly provided 
by M. Beckerle (University of Utah, Salt Lake City, UT) and vinculin by 
I.  Virtanen. The proteins were iodinated using Iodogen.  Iodogen (Pierce 
Chemical Co.,  Rockford, IL) was dissolved in chloroform (1 mg/rnl) and 
60 #1 was dried to the walls of an eppendorf tube under argon stream. The 
protein in 200  #1 of TSA  was  mixed  with 0.5  rnCi of 125I (Amersham 
Corp.) and the solution was transferred to the Iodogen-coated tube.  The 
reaction was terminated by transferring the solution to a tube containing 20 
#l of tyrosine (0.4 mg/mi) in borate-saline. Free 125I was separated from 
iodinated protein in a  PD10 Sephadex G-25 M  column (Pharmacia Fine 
Chemicals) equilibrated with 20 mM NaC1, 0.1 mM EDTA, 20 mM Tris 
Acetate, pH 7.6, 0.1%  /3-mercaptoethanol, 0.02%  NAN3. 
Interaction of a-actinin with Peptides 
125I-a-actinin or  m251-vinculin (60,000  cpm)  was  reacted  in an  affinity 
precipitation assay with 10 #1 of 1:1 slurry of peptide-Sepharose/TSA in 200 
#1 of binding buffer (50 mM Tris/HC1, pH 7.4, 0.15 M NaCI, 0.5% Tween 
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Sepharose was washed five times with binding buffer containing 0.1% BSA. 
Material bound to Sepharose was counted for radioactivity or eluted with 
0.1 M NaOH, 2% SDS and analyzed in SDS-PAGE and autoradiography. 
Tranexamic acid and r  acid added to some experiments were 
purchased from Sigma Chemical Co. 
Purification of  lCAM-I 
ICAM-1 was purified from placental lysate by immunoaflinity chromatogra- 
phy using Sepharose coupled-RR1/1  mAb as described (33) except that the 
lysis buffer and washing buffers contained 10 mM EDTA instead of MgC12. 
The purity of the material was verified by SDS-PAGE and silver staining. 
Solid-Phase Assay of  lCAM-l-r  Interaction 
Purified ICAM-1 or purified ,-actinin was allowed to bind to 96-well flat- 
bottomed polystyrene plates (Linbro, Flow Laboratories, Hamden,  CT) 
overnight at 4~  The following day the plates were washed and subse- 
quently blocked with 1% heat-denatured BSA in TSA overnight at ,I~  Di- 
lutions of t~-actinin were added to ICAM-1  or BSA-coated wells and dilu- 
tions of ICAM-1 to ~-actinin or BSA-coated wells. Binding buffer was used 
in all dilutions and washes. After overnight incubation at 4~  the wells were 
washed five times by flicking the plates. Bound c~-actinin was detected using 
rabbit  c~-actinin  serum  and  125I-protein  A  (Amersham Corp.).  Bound 
ICAM-1  was detected by CL203 mAb labeled with 125I using lodogen. 
Results 
The Distribution of Wild-l~ype ICAM-1 and 
Glycophosphatidylinositol-anchored ICAM-1 on 
Transfected COS Cells 
COS  cells  were  transfected with  cDNA  encoding  either 
ICAM-1 or an engineered form of  ICAM-1 which is anchored 
to the cell membrane through a glycophosphatidylinositol 
anchor.  The cell surface distribution of the two forms of 
ICAM-1  was examined by indirect immunofluorescence mi- 
croscopy. Wild-type ICAM-1 staining was most prominent in 
microvillar projections on the surface of the cells (Fig. 1 A). 
The distribution colocalized with F-actin staining present in 
these areas but not with actin-containing stress fibers (Fig. 
1 B). The majority of GPI-ICAM-1, on the other hand, was 
uniformly distributed on the cell membrane (Fig. 1 C). COS 
cells expressing GPI-ICAM-1 occasionally contained brightly 
stained round-shaped areas on the membrane or in the space 
between  cells  (Fig.  1  G).  These  apparently  represented 
membrane components shed by the cells and were not seen 
in cells expressing wild-type ICAM-1.  Treatment of the cells 
with a microfilament disrupting agent,  CCB, resulted in a 
loss of stress fbers and microvilli and formation of large 
F-actin clusters (Fig. 1, F and H). Concommitantly the dis- 
tribution of wild-type ICAM-1  in these cells was  altered. 
Most of the ICAM-1  in the CCB-treated cells colocalized 
with the areas containing clustered actin, although uniformly 
distributed ICAM-1  was somewhat increased in comparison 
with untreated cells (Fig.  1 E).  In contrast, GPI-ICAM-1 
distribution was not affected by CCB treatment (Fig.  1 G). 
These results suggested that in transfected COS cells wild- 
type ICAM-1  is associated with the actin-containing micro- 
filament network and that the interaction is mediated by the 
cytoplasmic or transmembrane domains of ICAM-1. 
The Distribution of  lCAM-1 in Lymphoid Cells 
EBV-transformed B-cells demonstrated an ICAM-1  distribu- 
tion pattern that differed from transfected COS cells. In a 
fraction of the cells (usually between 20 and 50 %), ICAM-1 
was concentrated into one side of the cell membrane, often 
into a small area in the uropod region (Fig. 2 A). Such a pat- 
tern was not typical for all cell surface components since sev- 
eral other B-cell membrane proteins that we examined were 
uniformly distributed (Fig. 2, B-G).  The accumulation of 
ICAM-1 in the uropod was detected in three EBV-transformed 
B-cell lines studied, JY,  KOS, and SLA. Two of the EBV- 
transformed lines were derived from patients with defective 
expression of leukocyte-integrins LFA-1, Mac-l, and p150/95 
indicating  that  the  expression  of receptor molecules  for 
ICAM-1  does not regulate its distribution (not shown). 
Regulation of  lCAM-1 Distribution in B-cell Lines 
To investigate how ICAM-1 localization is regulated in B-cell 
lines its distribution was  determined after treatment with 
agents that affect cellular functions (Fig. 3). Treatment of  the 
cells  with  the  energy-depleting  agent  NaN3  or  with  the 
divalent cation chelator EDTA decreased the number of cells 
in which ICAM-1  concentrated in the uropod region. Dis- 
ruption of microfilaments with CCB led to even more dras- 
tic change; virtually all cells had a uniform distribution of 
ICAM-1. Similarly, activation of  protein kinase C with PMA 
caused ICAM-1  to dislocate from the uropod and become 
uniform. In contrast to the CCB effect, disruption of micro- 
tubules with colchicine did not lead to a uniform distribution 
of ICAM-1 but increased the number of cells with polarized 
ICAM-1. 
Codistribution of  lCAM-I with ~-actinin 
The results described above suggested that a link exists be- 
tween  ICAM-1  and  the  actin-containing  cytoskeleton  in 
B-cells.  To  further  analyze  which  cytoskeletal  proteins 
might anchor ICAM-1 to microfilaments the cells were dou- 
ble stained to localize ICAM-1  and various cytoskeletal ele- 
ments. The staining of JY cells revealed a striking colocali- 
zation between ICAM-1 and t~-actinin (Fig. 4, A and E). All 
cells  that  had  polarized  ICAM-1  also  showed  polarized 
t~-actinin.  On the other hand, talin, tensin (Fig. 4, Fand G), 
and vinculin (not shown), three other cytoskeletal proteins, 
demonstrated no preferential distribution in the areas where 
ICAM-1  was  concentrated.  PMA  treatment,  which  dis- 
sociated ICAM-1  from concentrated areas, also resulted in 
a loss of polarized ot-actinin (not shown). The distribution 
of ICAM-1  on a Burkitt's lymphoma line Raji was not polar 
(Fig. 4 D). On typical Raji cells ICAM-1  was most promi- 
nently localized on microvilli-like hairy projections present 
on the cell surface. Accordingly, ot-actinin  was also more 
evenly distributed in Raji cells than in JY ceils (Fig. 4, D and 
H). A  slightly punctate a-actinin staining pattern gave an 
impression  of concentration of the  protein to  microvilli. 
However, colocalization with ICAM-1  was not as evident as 
in JY cells. 
Isolation of  lCAM-1 Cytoplasmic Peptide 
Binding Proteins 
To characterize molecules that associate with the cytoplas- 
mic  domain of ICAM-1,  a  28-amino acid peptide corre- 
sponding to the cytoplasmic sequence of ICAM-1  (ICAM- 
1,47s-505) (Fig. 5) was synthesized. The peptide was coupled 
to CNBr-activated Sepharose CL-4B and used as an affinity 
matrix. We have found that placental tissue can serve as a 
Carptn et al. Association  of lCAM-1 with c~-actinin  1225 Figure 1. The distribution  of wild-type ICAM-1 and GPI-ICAM-1 on COS cells and the effect of eytochalasin B on the distribution. COS 
cells transfected  with cDNA for wild-type ICAM-1 (,4, B, E, and F) or GPI-ICAM-1 (C, D, (7, and H) were grown on plastic slides. 
The cells were fixed and ICAM-1 was visualized by mAb and FITC-conjugated  goat F(ab')2 anti-mouse Ig (,4, C, E, and G). F-actin was 
visualized by rhodamine-phallacidin  (B, D, F, and H). In E-H, the cells were treated with 10 #g/ml of CCB for 60 min before fixation. 
Bar,  10 #m. 
The Journal of Cell Biology, Volume 118, 1992  1226 Figure 2. Immunofluorescence localization of membrane proteins on EBV-transformed  B-cell line JY. The cells were cytocentrifuged onto 
slides, fixed, and stained with mAb against ICAM-1 (A), LFA-1 (B), CIM3 (C), CIM4 (D), CD45 (E), LFA-3 (F), HLA (G), or a control 
mAb X63 (H) followed by FITC-conjugated goat F(ab')2 anti-mouse  Ig. Bar, 10 #m. 
source  for  immunoaffinity  purification  of  ICAM-1  (see 
Materials and Methods). Thus, it was predicted that it would 
also contain ICAM-l-associated proteins.  Solubilized pla- 
cental  proteins  were  passed  through  an  ICAM-1,47s-505- 
peptide-Sepharose column and after extensive washing the 
bound  material  was  eluted  either  with  soluble  ICAM- 
1,47s-505 peptide  or  with  EDTA  (Fig.  6  A).  Both  soluble 
ICAM-1,478_505 peptide and EDTA eluted a similar profile of 
polypeptides  from  the  column.  No  major  protein  bands 
could be detected in material eluted from the ethanolamine 
precolumn using either elution condition. In control experi- 
ments,  elution  of  the  ICAM-1,478_505-peptide-Sepharose 
column with an irrelevant peptide  (a  cytoplasmic domain 
peptide of B2-integrins,  CD18)  did not release any bound 
material from the column.  To analyze whether any of the 
proteins  bound  to  ICAM-1,47s_505-peptide-Sepharose  cor- 
related to known cytoskeletal structures, Western blot analy- 
sis was performed using different antisera (Fig. 6 B). Antise- 
rum against  ot-actinin reacted with a  100-kD band eluted 
from the column whereas talin, vinculin (Fig. 6 B), or tensin 
(not shown) antisera did not react with the eluted material. 
In 2-D-gel electrophoresis the  100-kD protein had a pI of 
5.3-5.5 (not shown) which correlates with the published pI 
of 5.46 for c~-actinin (9). 
uropod  crescent  uniform 
control  15.7 %  30.4 %  53.9 % 
NaN3  4.8 %  16.9 %  76.3 % 
EDTA  4.8 %  22.6 %  72.6 % 
CCB  0.0 %  1.9 %  90.1% 
Colchlclne  26.4 %  34.1%  39.5 % 
PMA  2.8 %  11.8 %  85.4 % 
Figure 3. The effect of various treatments on ICAM-1 distribution 
on JY cells. JY cells were incubated in the presence of the indicated 
drugs, cytocentrifuged on slides, fixed, and stained for ICAM-1. 
The distribution of ICAM-1 on the cell  surface was determined 
from 200 cells. The values represent an average of two experiments 
with virtually similar results. 
Association of  u-actinin with ICAM-1 
Cytoplasmic Domain 
ct-actinin was among the proteins that bound to an ICAM- 
1,47s-505-peptide column. However, the result did not prove a 
direct interaction with ICAM-1.  Therefore, further experi- 
ments were performed to determine if t~-actinin  can bind 
directly  to  ICAM-1,478_505-peptide or  immunoaffinity-puri- 
fled ICAM-1.  Purified a-actinin  and  another cytoskeletal 
protein, vinculin, were iodinated and incubated with ICAM- 
1,47s_505-peptide Sepharose. c~-actinin but not vinculin bound 
directly to the cytoplasmic domain of ICAM-1  (Fig. 7 A). 
The  interaction  between  Sepharose-bound  ICAM-1,47s_505 
and  ct-actinin  could  be  competed  with  soluble  ICAM- 
1,478-505 peptide (Fig.  7 B). 
An  interaction between purified ICAM-1  and  o~-actinin 
was  studied  in  two  reciprocal  solid-phase  assays.  Im- 
munoaffinity-purified ICAM-1  or purified ot-actinin was ab- 
sorbed to polystyrene plates  and  the plates  were blocked 
with BSA. Soluble ct-actinin or ICAM-1,  respectively, were 
added to the wells, unbound proteins were washed away, and 
the association with the immobilized proteins was measured 
Carptn et al. Association  of lCAM-1 with t~-actinin  1227 Figure 4. Double immunofluorescence staining of ICAM-1 and cytoskeletal proteins on EBV-transformed  B-cell line JY and on Burkitt's 
lymphoma line Raji. JY (A-C, and E-G) or Raji (D and H) cells were cytocentrifuged onto slides and fixed. ICAM-1 was detected with 
mAb and FITC-conjugated goat F(ab')2 anti-mouse Ig (A-D). Cytoskeletal proteins in the same cells were detected with rabbit antisera 
against ,-actinin (E and H), talin (F), or tensin (G) and rhodamine-conjugated goat F(ab')2 anti-rabbit  Ig. Bar, 10/zm. 
using  ct-actinin  antiserum  and  radiolabeled  protein  A  or 
anti-ICAM-1  mAb.  Bound c~-actinin was detected in wells 
containing immobilized ICAM-1 but not in wells coated with 
BSA  only (Fig.  8  A).  In  a  complementary assay,  soluble 
ICAM-1 bound to wells with immobilized ct-actinin, but not 
to control wells (Fig. 8 B). No radioactivity was detected in 
wells containing immobilized molecules if soluble ICAM-1 
or ct-actinin were not added (Fig. 8, A and B) demonstrating 
the specificity of the detection method. 
Analysis of the Region in ICAM-I Cytoplasmic 
Domain that Interacts with a-actinin 
To localize the region in the ICAM-1  cytoplasmic domain 
that mediates interaction with ot-actinin, affinity precipita- 
Peotide  Seouence 
ICAM-1,478-505 
ICAM-1,478-486 
ICAM-1,480-484 
ICAM-1,486-505 
ICAM-1,505-478 
Control 1 
2 
3 
4 
RORKIKKYRLOOAOKGTPMKPNTOATPP 
RQRKIKKYR 
RKIKK 
RLQQAQKGTPMKPNTQATPP 
PPTAQTNPKMPTGKQAQQLRYKKIKRQR 
GKKEKPEKKVKKSDC 
GKGDPKKPRGK 
KPDAAKKGVVC-arnide 
YNIMIEEDRRRRQ 
Figure  5. Peptides used for studies on ICAM-l-ot-actinin interaction. 
tion  experiments using  several  peptides  and  radiolabeled 
c~-actinin were performed. The different peptides are listed 
in Fig. 5. One of  the peptides contained the 28-ICAM-1 cyto- 
plasmic domain amino acids in reverse order. This peptide 
(ICAM-1,505-47s) bound to ot-actinin in a quantitatively simi- 
lar  way  as  ICAM-1,478_5o5 (Fig.  9  A).  This  result  demon- 
strated that the interaction is not specific for a specific amino 
acid  sequence.  The ICAM-1  cytoplasmic sequence has  a 
stretch of positively charged amino acids (three lys and three 
arg in  nine residues)  close to the transmembrane region. 
Two shorter peptides, one with all nine amino acids (ICAM- 
1,478-486) and  another  with  five  (ICAM-1,4~484) were  also 
tested for binding to a-actinin.  Both peptides were able to 
interact  with  c~-actinin  at  levels  comparable  to  ICAM- 
1,47s-505 peptide.  Moreover,  the  nine-amino  acid  peptide 
effectively competed for ot-actinin binding with the ICAM- 
1,47s-505 peptide (Fig. 9 A). The residues 478-486 appeared 
to solely be responsible for the interaction, since a peptide 
(ICAM-1,,86-505) containing the cytoplasmic amino acids ex- 
cept those residues did not bind to ct-actinin. 
Since positive charge may be important for the interaction 
we tested non-ICAM-l-derived peptides for c~-actinin bind- 
ing. We used three lysine-rich peptides and a peptide with 
several adjacent arginine residues; all the peptides having a 
net positive charge. None of these control peptides showed 
significant association with a-actinin (Fig.  9 A) indicating 
that net positive charge alone is not sufficient to provide in- 
teraction with a-actinin. 
Nature of  lCAM-l-tx-actinin Interaction 
In  further experiments the nature of t~-actinin  binding to 
ICAM-1,478_505 was characterized. The interaction appeared 
to be sensitive to an increase of ionic strength.  When the 
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noblot analysis of proteins eluted 
from  ICAM-1 cytoplasmic  do- 
main  peptide  column.  (A)  Pla- 
cental lysate was passed through 
an ICAM-1,478-505-peptide-Sepha- 
rose column and the column was 
washed extensively (lane 1). The 
following elution conditions were 
applied  sequentially:  soluble 
ICAM-1,478_~-peptide (0.1 mg/ 
rnl) (lanes 2 and 3), lysis buffer 
(lane 4), and lysis buffer with 10 
mM EDTA and  no divalent  ca- 
tions (lanes 5 and 6). Eluted ma- 
terial was analyzed in SDS-PAGE 
and  the  proteins  were  visual- 
ized by silver staining.  (B) Pro- 
teins from ICAM-l,47s-5os-peptide- 
Sepharose  column  elution  and 
from  a  control  platelet  lysate 
were  separated  in  SDS-PAGE 
and  detected  by  silver  staining 
or  blotted  to  nitrocellulose  fil- 
ters.  Cytoskeletal  proteins  were 
probed with the indicated rabbit 
antisera  or normal rabbit  serum 
(NRS) and ~2SI-protein  A. 
molarity of NaC1 was raised from 0.15 to 0.3 M or above the 
interaction was markedly reduced or totally abolished (Fig. 
9  B).  Chelation  of divalent  cations  with  EDTA  also  de- 
creased the binding of ol-actinin and ICAM-1,47s_5o5 (Fig.  9 
B) as could be expected, since o~-actinin was eluted from the 
ICAM-1,478_5o~-peptide-Sepharose  column with EDTA.  The 
requirement  of a  native  form of ot-actinin  was  tested  by 
denaturation  with  heat  or  SDS  before binding.  Although 
both treatments, either alone (not shown) or in combination 
(Fig.  9  B),  reduced  the  level of interaction,  a  significant 
amount of binding  remained between denatured  a-actinin 
and ICAM-1,478-~05. 
The presence of  lysine residues in the region of  the ICAM-1 
cytoplasmic domain  associating with  a-actinin  raised the 
possibility that the interaction might resemble plasminogen 
activator binding to plasminogen. This interaction is medi- 
ated by a lysine binding region in plasminogen and is effec- 
tively blocked with ~o-aminocarboxylic acids (35). We tested 
the effect of two o~-aminocarboxylic acids, tranexamic acid, 
and  e-aminocaproic acid on  ICAM-1,478_~os-peptide-o~-acti- 
nin binding.  Neither compound inhibited binding,  even at 
concentrations 100-fold greater than those reported to block 
the lysine binding sites (Fig. 9 B), suggesting no similarity 
between the two types of interactions. 
Figure 7. Association of puri- 
fied c~-actinin  but not vinculin 
with  ICAM-1,47s_505-peptide. 
(A) 60,000 cpm of 125I-cx-ac- 
tinin  or  12~I-vinculin was in- 
cubated  with  ICAM-1,47s-505- 
peptide-Sepharose.  Unbound 
material was removed by wash- 
ing and the Sepharose-bound 
radioactivity  was  counted. 
(B) 60,000 cpm of 125I-r 
nin was incubated with ICAM- 
1,,Ts_505-peptide-Sepharose 
(lane 1), with ICAM-1,478-5os- 
peptide-Sepharose in presence 
of fivefold excess  of soluble 
ICAM-l,,~_505-peptide (lane 2) 
or with control ethanolamine- 
Sepharose (lane 3). Bound ma- 
terial was eluted, separated in 
SDS-PAGE,  and  autoradio- 
graphed. 
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Figure 8. Radioimmunoassay showing association 
of a-actinin with purified ICAM-1. Soluble c~-acti- 
nin (A) or ICAM-I (B) was added to wells coated 
with ICAM-1 (A) or ct-actinin (B),  respectively, 
and blocked with BSA. In A, bound ot-actinin was 
detected with a-actinin antiserum and ~25I-labeled 
protein A. In B, bound ICAM-I was detected by 
t25I-labeled ICAM-1 mAb.  Dilutions  in  B  were 
made from ICAM-1 stock obtained from immuno- 
affinity chromatography purification. Mean -t- SD 
of triplicate wells. 
Discussion 
In this study we show that ICAM-1, a cell surface protein in- 
volved  in  cell  adhesion,  is  associated  with  the  actin- 
containing  cytoskeleton.  This  was  first  suggested by our 
findings  that the distribution  of ICAM-1  in both adherent 
COS  cell transfectants  and  in  nonadherent  B-cell  lines  is 
modified  by  agents  that  dissociate  the  actin-containing 
microfilament network but  not  by disruption  of microtu- 
bules.  The different distribution  of wild-type ICAM-1  and 
GPI-ICAM-1 indicates that such an interaction is mediated 
through the transmembrane or cytoplasmic domains of the 
molecule. 
The localization of wild-type ICAM-1 in transfected COS 
cells was different from most of the B-cell lines studied.  In 
the B-cells ICAM-1 was often concentrated to the uropod re- 
gion of the ceils whereas in COS cells preferential staining 
of the  microvillar projections  was  detected.  Whether  the 
more intense ICAM-1 staining in the microvilli truly reflects 
higher concentation of the molecules per surface area or is 
merely a result of additive effects of membrane projections 
is not clear but comparison to the uniform cell surface stain- 
ing pattern of GPI-ICAM-1 suggests that ICAM-1 actually 
is more prominent on the microvilli. 
A polarized distribution of ICAM-1 was evident in a large 
fraction of cells in all three EBV-transformed B-cell lines 
studied but not in the Burkitt's lymphoma line Raji, in which 
ICAM-1 was most prominent in microvilli. Polarized distri- 
bution of ICAM-1 was originally reported for the T cell line 
HSB-2 (18).  We were unable to confirm this finding on two 
samples of the cell line, including the one previously studied, 
and found little expression of ICAM-1 on this line.  In the 
EBV-transformed B-cell lines accumulation of ICAM-1 in the 
uropod does not appear to be due to interaction with LFA-1 
on the cell surface, because a  similar staining pattern was 
seen  in  cells  derived  from leukocyte adhesion  deficiency 
(LAD) patients,  which do not express LFA-1 (1). 
Several lines of evidence indicated ot-actinin as a cytoskel- 
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Figure  9.  Binding of purified  t~-actinin to 
ICAM-l-derived and control  peptides and 
the nature of the interaction between u-acti- 
nin  and  ICAM-1,478-486. (A)  =25I-a-actinin 
was incubated with the indicated Sepharose- 
coupled peptides listed in Fig. 5. In one of 
the reactions 10-fold  molar excess of soluble 
ICAM-1,478-486 was added.  Unbound mate- 
rial was washed away and the radioactivity 
remaining in Sepharose beads was counted. 
(B) ICAM-1,478_5os-peptide Sepharose  was 
incubated with 60,000  cpm of ~25I-c~-acti- 
nin in binding buffer (no treatment)  or in 
binding buffer containing 0.3 M NaCI, with 
=25I-c~-actinin  denatured  by  heating  at 
100~  in 2%  SDS for 15 min, with  125I- 
c~-actinin in presence of 10 mM EDTA and 
no divalent cations,  or with  125I-c~-actinin 
in  presence  of  tranexamic  acid.  After 
washes  the  ICAM-1,47s_505-peptide-Sepha- 
rose bound radioactivity was counted. The 
results are expressed as percentage of cpm 
compared with control. 
etal protein that can associate to ICAM-1. ~actinin could be 
enriched from placental lysates using ICAM-1 cytoplasmic 
peptide Sepharose affinity chromatography.  Also,  a  direct 
interaction  was  demonstrated between ICAM-1,478_~0s pep- 
tide and purified ct-actinin as well as between native purified 
ICAM-1  and ot-actinin.  Finally,  a  strict colocalization and 
comodulation was shown between ICAM-1 and ct-actinin but 
not between ICAM-1 and other B-cell cytoskeletal proteins 
examined. The immunofluorescence analysis revealed a polar- 
ized distribution of ot-actinin. The distribution in EBV-trans- 
formed B-cell lines is thus different from other cells in which 
ot-actinin is localized along actin fibers, in focal adhesions, 
in podosomes, and in myotendinous junctions (12).  Most of 
these studies, however, were performed with adherent cells 
which frequently differ from nonadherent cells in cytoskel- 
etal organization.  Nonerythroid spectrin, a protein sharing 
sequence homology with ct-actinin (4, 60),  for instance, in 
lymphoid ceils often shows a polarized distribution which re- 
sembles that of tx-actinin (6,  13, 44), whereas in most other 
cell types it is organized as a subplasmalemmal network (57). 
The function of ot-actinin has remained in many respects 
unclear.  The protein has actin-binding properties (36)  and 
has been shown to interact with another cytoskeletal protein, 
vinculin and with certain lipids (10, 41,  59). Based on these 
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been suggested to participate in anchoring of actin filaments 
to the cell membrane (36), possibly by acting as a distal link 
in a chain of several interacting molecules (7).  The present 
results and a study showing an interaction between the cyto- 
plasmic domain of the/3t subunit of the fibronectin receptor 
and cr  (40)  suggest a more direct role for ct-actinin 
as  a  link between  some cell membrane proteins  and the 
microfilament network. A brief study recently described an 
interaction between ICAM-1 and actin but also in that paper 
the possibility that a linking protein would mediate the as- 
sociation, was raised (58).  ct-actinin  is not the only major 
protein from placental lysates that binds to ICAM-1,47s_505 
peptide. The nature of the other, unidentified proteins that 
also  elute  from the ICAM-1  cytoplasmic domain peptide 
column needs to be resolved before the possibility of alterna- 
tive or additional linkages between ICAM-1 and cytoskele- 
ton can be addressed. 
The experiments with various ICAM-1  cytoplasmic do- 
main peptides indicate that the region of the cytoplasmic tail 
near the transmembrane domain that contains several  posi- 
tively charged residues is responsible for the association be- 
tween ICAM-1 and a-actinin. Two shorter peptides contain- 
ing this charged region bound ct-actinin at levels comparable 
with the ICAM-1,47s_s05 peptide and the ICAM-1,47s_486 pep- 
tide effectively competed for a-actinin binding with ICAM- 
1,47s-505 peptide. Moreover, the ICAM-1 cytoplasmic peptide 
which lacked the eight residues was unable to interact with 
a-actinin. A peptide containing the cytoplasmic amino acids 
in reverse order also bound to a-actinin and competed for 
the binding with specific peptide (not shown) suggesting that 
the  overall configuration of charge  is  more  important to 
binding than stereoselective interactions. The electrostatic 
nature of the interaction was supported by other observa- 
tions.  Although  binding  occurred  at  physiologic  ionic 
strength  (0.15 M),  increasing  ionic  strength  (0.3-1.0  M 
NaCl) rapidly decreased binding; the binding could be de- 
creased,  but  not  totally  abolished  by  denaturation  of 
ct-actinin;  and finally, an interaction was detected between 
a-actinin and poly-L-lysine-Sepharose (not shown). 
The presence of charged residues in the cytoplasmic do- 
main  is  characteristic  of transmembrane proteins.  These 
residues are believed to form an anchor, arresting transloca- 
tion across the bilayer during biosynthesis and assuring the 
correct topological orientation (8). It was of interest to test 
whether any positively charged peptide would associate with 
ot-actinin.  We tested four control peptides derived from bio- 
logical sequences unrelated to ICAM-1.  Although all pep- 
tides had a  net positive charge they did not demonstrate 
significant interaction with tx-actinin,  indicating some de- 
gree of sequence specificity for the charged residues. Com- 
parison  of the  ICAM-1  cytoplasmic domain  sequence  to 
integrin-/3~ cytoplasmic domain and  membrane  immuno- 
globulin (mIg) cytoplasmic domain, another membrane pro- 
tein potentially associating with a-actinin (25), reveals that 
the only common denominator is KXK where X  is E  in 
integrin-/~ subunit (55),  I in ICAM-1,  and V in mIg (45). 
The control peptide no. 1, however, also contains a KVK se- 
quence but mediated little interaction with ct-actinin indicat- 
ing a more complex requirement for binding. The ICAM-1 
cytoplasmic domain contains no acidic residues,  whereas 
such residues are present in most cytoplasmic domains and 
in our control peptides. 
Binding domains for lysine-rich sequences are present in 
some neural cell receptors and in the kringles of plasmino- 
gen (32, 50). Occupation of the lysine binding sites induces 
conformational changes in plasminogen and affects its enzy- 
matic activity (15, 56). The association between ICAM-1 and 
ot-actinin,  however, is not identical to the plasminogen path- 
way since ~0-aminocarboxylic  acids which compete for the 
lysine binding sites in plasminogen (35) did not affect ICAM- 
1-o~-actinin interaction. The interaction was partially depen- 
dent on divalent cation concentration which is of interest 
since the COOH-terminal region of ct-actinin  contains two 
EF hand-like calcium binding motifs (38). 
Association with ot-actinin may be important to the func- 
tion of several types of adhesion molecules. Otey et al. (40) 
recently demonstrated that ot-actinin binds to a/~t integrin 
cytoplasmic domain peptide and to purified chicken smooth 
muscle (~) integrin and to the platelet integrin gp lib/Ilia; 
here we show an interaction between a-actinin and ICAM-1, 
a member of the immunoglobulin superfamily of adhesion 
receptors. We do not currently know whether ICAM-1 and 
the integrins bind to the same region in ot-actinin.  However, 
some similarity in the nature of the interactions is suggested 
by the comparable sensitivity of both interactions to changes 
in ionic strength. In adherent cells a colocalization has been 
demonstrated between ~  integrins and a-actinin in  focal 
adhesions.  However,  our immunofluorescence localization 
studies in the B-cell lines do not suggest a similar association 
between ct-actinin and LFA-1, a  member of the leukocyte 
(/32) integrins. 
The role of a cytoskeletal interaction in ICAM-1 functions 
remains  elusive.  The  GPI  form of ICAM-1,  which  lacks 
cytoskeletal associations, mediates adhesion to LFA-1 at lev- 
els comparable with the wild-type ICAM-1 and both forms 
support binding and internalization of human rhinoviruses 
equally (52,  53).  Internalization of a  major group human 
rhinovirus does not require cytoplasmic or transmembrane 
domains  of ICAM-1  (53).  We  have  recently  shown  that 
purified ICAM-1  incorporated in artificial membranes can 
support lymphocyte motility (14,  19), which may be of im- 
portance  during  lymphocyte emigration to  inflammatory 
foci (17, 61). Another adhesion ligand, LFA-3, also provided 
a  matrix for locomotion but an immobile transmembrane 
form of the molecule was severalfold more efficient in sup- 
porting cell movement than a freely mobile GPI-anchored 
form (14). In analogy, a cytoskeletal anchorage which im- 
mobilizes ICAM-1 on endothelial cells and cells within tis- 
sues could be crucial for providing a firm foundation or foot- 
hold for leukocytes undergoing transendothelial emigration 
and subsequent migration within tissues. 
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